ABCL holders · BlackRock Finance, Inc. 13F · ABCL stock
BlackRock Finance, Inc. Abcellera Biologics Inc (ABCL) 13F holding
BlackRock Finance, Inc. reported 1,907,897 ABCL shares valued at $5.65B as of 2024-06-30 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2024-06-30 | 1,907,897 | $5.65B | COM |
| 2024-06-30 | 619,296 | $1.83B | COM |
| 2024-06-30 | 537,494 | $1.59B | COM |
| 2024-06-30 | 366,574 | $1.09B | COM |
| 2024-06-30 | 133,057 | $393.8M | COM |
| 2024-06-30 | 125,915 | $372.7M | COM |
| 2024-06-30 | 95,337 | $282.2M | COM |
| 2024-06-30 | 8,658 | $25.6M | COM |
| 2024-06-30 | 4,949 | $14.6M | COM |
| 2024-06-30 | 4,300 | $12.7M | COM |
| 2024-03-31 | 1,923,840 | $8.71B | COM |
| 2024-03-31 | 578,395 | $2.62B | COM |
| 2024-03-31 | 516,686 | $2.34B | COM |
| 2024-03-31 | 368,953 | $1.67B | COM |
| 2024-03-31 | 266,288 | $1.21B | COM |
| 2024-03-31 | 133,078 | $602.8M | COM |
| 2024-03-31 | 94,971 | $430.2M | COM |
| 2024-03-31 | 8,942 | $40.5M | COM |
| 2024-03-31 | 4,949 | $22.4M | COM |
| 2024-03-31 | 4,462 | $20.2M | COM |
| 2023-12-31 | 1,843,321 | $10.53B | COM |
| 2023-12-31 | 552,292 | $3.15B | COM |
| 2023-12-31 | 548,820 | $3.13B | COM |
| 2023-12-31 | 422,966 | $2.42B | COM |
Not investment advice. Cached 13F row, not EDGAR XML.